Document is current
Any future updates will be listed below
-
Authors
Song, Min-Ae
Mori, Kellie M.
McElroy, Joseph P.
Freudenheim, Jo L.
Weng, Daniel Y.
Reisinger, Sarah A.
Brasky, Theodore M.
Wewers, Mark D.
Shields, Peter G.
-
Funding
Funding for this research was provided by:
National Institutes of Health (P50CA180908)
National Institutes of Health (P30 CA016058)
National Institutes of Health (P50CA180908)
National Institutes of Health (P50CA180908)
National Institutes of Health (P30 CA016058)
National Institutes of Health (P50CA180908)
National Heart, Lung, and Blood Institute (R21HL147401)
National Heart, Lung, and Blood Institute (R21HL147401)
National Heart, Lung, and Blood Institute (R21HL147401)
National Heart, Lung, and Blood Institute (R21HL147401)
Prevent Cancer Foundation
Ohio State University research start-up funds
Ohio State University Pelotonia Intramural Research Funds
- License Information
-
More Information
Article History
Received: 11 March 2023
Accepted: 1 October 2023
First Online: 11 October 2023
Declarations
:
: The study’s protocol was approved by the OSU’s Institutional Review Board.
: PGS has served as an expert witness and consultant in tobacco company litigation on behalf of plaintiffs. The other authors declare that they have no potential competing interests.
